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Abstract
Background: Elderly patients are evaluated for liver transplantation (LT) with increasing frequency, but
outcomes in this group have not been well defined.
Methods: A linkage of the Scientific Registry of Transplant Recipients (SRTR) and the University
HealthSystem Consortium (UHC) databases identified 12 445 patients who underwent LT during 2007–
2011. Two cohorts were created consisting of, respectively, elderly recipients aged ≥70 years (n = 323)
and recipients aged 18–69 years (n = 12 122). A 1:1 case-matched analysis was performed based on
propensity scores.
Results: Elderly recipients had lower Model for End-stage Liver Disease (MELD) scores at LT (median 15
versus 19; P < 0.0001), more often underwent transplantation at high-volume centres (46% versus 33%;
P < 0.0001) and more often received grafts from donors aged >60 years (24% versus 15%; P < 0.0001).
The two cohorts had similar hospital lengths of stay, in-hospital mortality, hospital costs and 30-day
readmission rates. There were no differences in graft survival between the two cohorts (P = 0.10), but
elderly recipients had worse longterm overall survival (P = 0.009). However, a case-controlled analysis
confirmed similar perioperative hospital outcomes, graft survival and longterm patient survival in the two
matched cohorts.
Conclusions: Elderly LT recipients accounted for <3% of all LTs performed during 2007–2011. Selected
elderly recipients have perioperative outcomes and survival similar to those in younger adults.
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Introduction
An increasing number of older patients with end-stage liver
disease (ESLD) are evaluated for liver transplantation (LT). In fact,
patients aged ≥65 years represent one of the fastest-growing
patient populations in LT.1 The most extreme of these patients,
those aged ≥70 years, are associated with several difficult clinical
dilemmas. Firstly, advanced patient age is associated with higher
risk and poorer outcomes after complex surgical procedures.2 Spe-
cific to the field of transplantation, advanced recipient age is asso-
ciated with increased risk for infection3 and cardiovascular
disease, increased resource utilization4 and lower patient survival.5
As the number of adult candidates on the waiting list continues to
rise and organ availability remains unable to fully meet this
demand, proper organ allocation and utilization are critically
important. Unfortunately, national data that might guide the
addressing of these issues for an expanding older LT recipient
population are scarce in the USA.
The goal of the present study was to evaluate the safety and
efficacy of LT in patients aged ≥70 years. A novel database created
by linking two resources was used to evaluate perioperative hos-
pital outcomes, graft survival and patient survival in the elderly
patient population and to compare these findings with those in a
younger cohort. This evaluation should contribute to the estab-
lishment of baseline outcomes for elderly subjects and provide
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benchmark data for future studies on the role of LT in these
patients.
Materials and methods
Database creation and patient selection
The Scientific Registry of Transplant Recipients (SRTR) is admin-
istered by the Chronic Disease Research Group of theMinneapolis
Medical Research Foundation and maintains scientific data on
solid organ transplantation. The SRTR Analysis File was queried
to identify all patients (n = 28 880) who underwent LT from 1
January 2007 to 31 December 2011.
The University HealthSystem Consortium (UHC) consists of
118 academic medical centres and 298 affiliated hospitals and
represents >90% of non-profit academic medical centres in the
USA.6 The UHC Clinical Database/Resource Manager is an
administrative database that maintains patient and hospital stay
data so that an organization’s clinical outcome performance and
resource utilization can be assessed. Complete data files were
available for the period from 1 January 2007 to 31 December 2011.
Patients undergoing LT were identified using International Clas-
sification of Diseases Version 9 (ICD-9) procedural codes. Over
the same 2007–2011 period, 19 382 patients underwent LT at
67 centres.
The SRTR and UHC databases were linked in a manner that has
been previously described.7,8 Common database variables were
used to match patients across each dataset and included: recipient
age at time of LT; date of LT; recipient gender, and transplantation
centre. Recipients aged <18 years and recipients undergoing
repeat transplantation were excluded from the study database.
This SRTR–UHC linked database contained 12 445 patients sub-
mitted to LT during 2007–2011 and represented 43% of all LT
procedures performed in the USA over this 5-year period. This
cohort was verified as representing donor, recipient and centre
characteristics similar to those of the entire SRTR LT database
population during the period under study.
Two patient cohorts were created from the linked SRTR–UHC
database using recipient age at the time of LT. The elderly cohort
consisted of all patients in the linked database who were aged ≥70
years at the time of LT (n = 323, 2.6%). The remaining patients
aged 18–69 years (n = 12 122) were used for comparison. Recipi-
ent, donor and transplant centre characteristics were compared
between the cohorts. The primary purpose of this study was the
evaluation of outcomes in the elderly patient cohort, which
included graft survival, patient survival, and hospitalization
details such as length of stay (LoS) and hospital costs, and rates of
30-day hospital readmission and perioperative mortality.
A case-matched cohort for each group (n = 312) was created
using propensity scores and a matching algorithm.9 The propen-
sity scores were created based on the following variables: recipient
sex; recipient race; recipient Model for End-stage Liver Disease
(MELD) score at the time of transplant; donor age; donor type;
donor risk index (DRI) score, and transplant centre volume. These
variables were utilized to create a propensity score because they
differed significantly between recipients aged 18–69 years and
those aged ≥70 years on unadjusted analysis. Hospitalization out-
comes, graft survival and patient survival were then compared
between the matched cohorts.
Study variables
Recipient and donor race were categorized into four groups:
White; Black; Hispanic, and other. Pre-transplant MELD score
was calculated for each recipient as previously described10 and
recipients were stratified into four groups with MELD scores of
6–13, 14–19, 20–27 and 28–40, respectively. Donor type was cat-
egorized according to whether the organ was sourced from a
standard criteria donor (SCD), an expanded criteria donor
(ECD), or represented a donation after cardiac death (DCD).
Expanded criteria donation was based on the United Network for
Organ Sharing kidney definition, which included a donor age of
≥60 years or a donor age of 50–59 years with at least two of history
of hypertension, cerebrovascular accident as the cause of death
and serum creatinine of >132.6 μmol/l. The DRI was calculated as
previously described.11 Centres were ranked according to annual
case volumes and stratified into tertiles, representing low-volume
centres [the third of centres with the lowest annual case volume,
ranging from five to a mean ± standard deviation (SD) of 56 ± 4
transplantations per year], medium-volume centres (middle third
of centres based on a mean ± SD case volume of 62 ± 6 to 99 ± 10
transplantations per year), and high-volume centres (upper third
of centres based on a mean ± SD case volume of 102 ± 9 to 172
transplantations per year).12 Centre volume was recalculated for
each year analysed in the study and rankings were based on the
number of procedures performed per year, not on cumulative
totals. Centres performing fewer than five procedures per year
were excluded from the centre volume analysis.
Statistical analysis
Statistical analysis was performed using sas Version 9.3 (SAS
Institute, Inc., Cary, NC, USA). A P-value of <0.05 was considered
to indicate statistical significance. Study variables were compared
between the two cohorts using chi-squared analysis for categorical
variables and Wilcoxon rank-sum tests for continuous variables.
Graft and patient survival were estimated using Kaplan–Meier
survival curves. The log-rank test was used to determine any sta-
tistical difference (P < 0.05) in survival between the study cohorts.
The median follow-up for the entire study population was 2 years.
This study was approved by and conducted in accordance with
the criteria of the University of Cincinnati Institutional Review
Board.
Results
Baseline comparison of recipient, donor and
centre characteristics
Over the 5-year period of 2007–2011, LT was performed in 323
elderly patients who accounted for only 2.6% of all LTs identified
in this study. Recipient characteristics for the elderly (≥70 years of
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age) and non-elderly (18–69 years) cohorts are listed in Table 1.
Although older recipients had medical comorbidities similar to
those of the younger cohort, there were several notable differences
between the study groups. Elderly recipients were more likely to
have received a MELD exception (52% versus 29%), and had
lower MELD scores at the time of LT (median score: 15 versus 19).
Donor characteristics for the two cohorts are listed in Table 2.
Donor race, donor cause of death, and organ allocation were
similar between the two cohorts. However, elderly patients were
more likely to be recipients of allografts from donors aged >60
years (24% versus 15%) and received allografts with higher
DRI scores compared with the younger cohort (DRI score >1.8:
28% versus 22%). Additionally, elderly recipients were
more frequently transplanted at high-volume centres (46%
versus 33%) compared with recipients aged 18–69 years
(Table 1).
Unadjusted perioperative outcomes were compared between
the two cohorts. Although elderly recipients were less likely to be
Table 1 Unadjusted characteristics of liver transplant patients aged 18–69 years (n = 12 122) and ≥70 years (n = 323)
Recipients aged 18–69 years Recipients aged ≥70 years P-value
Male, n (%) 8184 68% 200 62% 0.03
Race, n (%) <0.001
White 8785 72% 230 71%
Black 1230 10% 18 6%
Hispanic 1343 11% 31 10%
Other 764 6% 44 14%
Insurance, n (%) <0.001
Private 7432 61% 61 19%
Government 4494 37% 260 81%
Other 196 2% 2 0.6%
BMI, kg/m2, median (IQR) 27.48 (24.12–31.75) 26.08 (23.30–28.90) <0.001
Recipient medical history, n (%)
Diabetes 2882 24% 89 28% 0.12
Angina 287 3% 21 7% <0.001
Haemodialysis 919 8% 15 5% 0.05
Ventilator 462 4% 10 3% 0.51
Bacterial peritonitis 641 6% 13 4% 0.28
Portal vein thrombosis 362 3% 15 5% 0.10
TIPS 720 6% 18 6% 0.73
MELD exception 3522 29% 169 52% <0.001
MELD score <0.001
6–13 3325 27% 127 39%
14–19 3081 25% 92 28%
20–27 2996 25% 63 20%
28–40 2720 22% 43 13%
Transplant centre volume <0.001
Lower third 4039 33% 95 29%
Middle third 4104 34% 80 25%
Upper third 3963 33% 148 46%
Aetiology of liver disease <0.001
Viral 4663 38% 82 25%
HCC 1355 11% 63 20%
Alcohol 1560 13% 39 12%
NASH 1515 13% 70 22%
Other 3028 25% 69 21%
BMI, body mass index; IQR, interquartile range; HCC, hepatocellular carcinoma; MELD, Model for End-stage Liver Disease; NASH, non-alcoholic
steatohepatitis; TIPS, transjugular intrahepatic portosystemic shunt.
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discharged to home after LT, both groups had similar hospital LoS,
intensive care unit LoS, direct costs, and rates of perioperative
mortality and 30-day readmission. Graft and patient survival are
depicted in Fig. 1. Elderly patients had similar graft survival (P =
0.10) (Fig. 1a), but worse overall survival (P = 0.009) (Fig. 1b).
Rates of 1-, 3- and 5-year overall survival in elderly recipients were
84.9% [95% confidence interval (CI) 80.3–88.4], 74.0% (95% CI
67.9–79.1) and 64.1% (95% CI 54.6–72.1), respectively. Rates of
1-, 3- and 5-year overall survival in the younger cohort were
89.4% (95% CI 88.9–90.0), 79.7% (95% CI 78.9–80.6) and 72.3
(95% CI 71.0–73.6), respectively.
Adjusted outcomes with case-matched analysis
A case-matched analysis of outcomes was performed using
matched cohorts created from propensity scores. The 1:1 match-
ing algorithm identified two matched cohorts (n = 312 in each) in
which all differences between donor and recipient characteristics
were eliminated. This allowed for the direct comparison of out-
comes between the study cohorts, which again demonstrated
similar perioperative outcomes (Table 3). There was no detectable
difference in graft survival at 1 year between the elderly cohort
and those aged 18–69 years (93% versus 89%). Graft and patient
survival were evaluated in the matched cohorts and are displayed
Table 2 Unadjusted characteristics of donors of liver grafts to liver transplant patients aged 18–69 years (n = 12 122) and ≥70 years (n = 323)
Recipients aged 18–69 years Recipients aged ≥70 years P-value
Male, n (%) 7204 59% 196 61% 0.65
Age of donor, n (%) <0.001
<40 years 5425 45% 139 43%
40–49 years 2466 20% 55 17%
50–59 years 2337 19% 51 16%
60–69 years 1386 11% 46 14%
≥70 years 508 4% 32 10%
Race, n (%) 0.97
White 8097 67% 220 68%
Black 2213 18% 56 17%
Hispanic 1394 12% 36 11%
Other 418 3% 11 3%
Donor type, n (%) 0.02
SCD 7895 68% 193 61%
ECD 3058 27% 97 31%
DCD 589 5% 24 8%
Split graft, n (%) 730 6% 15 5% 0.30
BMI, kg/m2, median (IQR) 26.23 (23.02–30.24) 25.77 (22.60–29.80) 0.16
Cause of death, n (%) 0.45
Trauma 4003 33% 110 34%
Anoxia 2523 21% 74 23%
Cerebrovascular accident 4714 39% 122 38%
Other 882 7% 17 5%
Organ allocation, n (%) 0.80
Local 8600 71% 225 70%
Regional 2265 19% 61 19%
National 1257 10% 37 11%
Donor risk index, n (%) 0.05
<1.2 3737 31% 96 30%
1.2–1.49 3179 26% 78 24%
1.5–1.79 2551 21% 58 18%
>1.8 2655 22% 91 28%
Cold ischaemia time, h, median (IQR) 6.5 (5–8) 6 (5–8) 0.15
Warm ischaemia time, min, median (IQR) 40 (30–50) 38 (30–48) 0.26
BMI, body mass index; DCD, donation after cardiac death; ECD, expanded criteria donor; IQR, interquartile range; SCD, standard criteria donor.
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in Fig. 2. There were no differences in overall graft survival
(P = 0.35) (Fig. 2a) or patient survival (P = 0.13) (Fig. 2b).
Discussion
This study utilized a linkage between the SRTR and UHC clinical
databases to evaluate the current status of LT in elderly patients.
Elderly patients represent <3% of LT recipients operated during
2007–2011. An unadjusted analysis of outcomes in this cohort
and in patients aged 18–69 years demonstrated similar
perioperative outcomes and graft survival. However, in the
unadjusted analysis elderly patients were found to have worse
overall survival. Several differences existed at baseline between
the study groups including in recipient demographics, pre-
transplant MELD scores, donor age and type, DRI score, and
transplant centre. In order to account for these differences, pro-
pensity scores were used to create matched cohorts for compari-
son. In this matched analysis, there were no differences in
patient or graft survival. This matched analysis suggests that
equivalent outcomes can be achieved in elderly recipientsand
that advanced recipient age should not be used as a barrier to LT.
Recent data for waitlist registrants on the SRTR registry suggest
that <12% of waitlisted patients are aged ≥65 years, but this pro-
portion has steadily increased over the past decade. Continued
improvements in care in pre- and post-transplant medicine and
surgery suggest that this age group will continue to grow on the
waiting list.With this demographic shift in the ESLD and national
populations, more elderly patients will be considered for LT and
the use of scarce donor livers will need to be addressed because
these recipients have a shortened lifespan compared with younger
recipients. Despite the shortened lifespan, single-centre reports



























































Figure 1 (a) Unadjusted graft survival and (b) patient survival in elderly liver transplant recipients (aged ≥70 years) and recipients aged 18–69
years
Table 3 Perioperative outcomes in case-matched liver transplant patients aged 18–69 years (n = 312) and ≥70 years (n = 312)
Recipients aged 18–69 years Recipients aged ≥70 years P-value
Hospital LoS, days, median (IQR) 10 (7–15) 10 (7–16) 0.97
ICU LoS, days, median (IQR) 3 (1–5) 3 (2–6) 0.70
Mortality, n (%) 12 4% 10 3% 0.67
Routine discharge home, n (%) 264 85% 239 77% 0.01
Direct cost, US$, median (IQR) 111 000 (87 000–145 000) 108 000 (80 000–155 000) 0.90
30-day readmission, n (%) 108 35% 102 33% 0.59
1-year graft failure, n (%) 35 11% 23 7% 0.10
ICU, intensive care unit; IQR, interquartile range; LoS, length of stay.
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patients.13 Studies in support of LT in geriatric recipients docu-
ment 5-year survival rates of close to 70%.14,15 Schwartz and col-
leagues reported similar survival in hepatocellular carcinoma
(HCC) patients aged ≥70 years compared with younger recipi-
ents.16 Another recent report attempted to define five prognostic
factors for outcome in recipients aged >60 years and included
ventilator status, diabetes mellitus, hepatitis C virus, creatinine
levels of ≥1.6 mg/dl, and a combined recipient and donor age of
≥120 years.17 The present review of the literature focused on recent
studies in the context of recent improvements in the care of LT
recipients because many studies conducted in previous decades
reported inferior outcomes in older recipients.18 The present
report confirms previous findings with short-term follow-up of
equivalent survival, but is the first to report a multicentre review
of peritransplant hospital utilization and outcomes in these
patients. Discharge disposition was the only perioperative
outcome for which the two groups differed significantly. Further
research is needed to determine the impact of this variable on
outcomes and cost-effectiveness after LT.
Growing concern regarding post-LT outcomes has led to an
increased focus on selection among both donors and candidate
recipients. The evaluation of potential recipients requires some
complex clinical decision making with regard to their general
health, the severity of their ESLD and their potential survival after
LT. The MELD allocation system is based on the risk for mortality
without LT and therefore does not take into account survival-
associated risk after LT. This is dependent on the practitioner at
the transplant centre. It is a crucial issue in the context of elderly
patients because their overall survival is already limited and docu-
menting a longterm survival benefit with LT may be difficult, as it
is with kidney transplant.19,20 The present data attempt to address
this issue by incorporating all factors in the transplant process
(donor, recipient and centre characteristics) and using propensity
scores to control for patient selection and bias. This study was able
to eliminate all differences in demographic characteristics
between the two groups and subsequently show that, at a median
follow-up of 2 years, patient survival does not differ between
them. This study is important because the elderly population is
growing and is expected to impose an increasing burden of
disease. Although this population accounted for only 2.6% of all
LTs performed over the 5-year period surveyed in the current
study, this proportion is likely to increase over time.
The data presented here were sourced from the SRTR and UHC
databases in combination in order to provide insight into
transplant-specific variables and to facilitate an examination of
perioperative andpostoperativemetrics from the hospital perspec-
tive.Patient selectionmust be optimal and the timing of orthotopic
LT (OLT) critical if it is to achievemaximal utility in ESLDpatients.
Key factors for success include the provision of lifelong medical
follow-up and medications, access to care when ill, and the provi-
sion of appropriate education and resources to manage any com-
plications. Increasing insurance regulation, restrictions in the use
of medications and centre-based restrictions for listing and trans-
plantmaymake these differences larger in the future.Despite these
unknowns, the present study nonetheless demonstrates differences



























































Figure 2 (a) Adjusted graft survival and (b) patient survival in case-matched elderly liver transplant recipients (aged ≥70 years) and recipients
aged 18–69 years
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not hospitalized), but does not support any conclusion onwhether
these factors played a role in the worse outcome in the elderly
group. The utilization of hospital resources was similar in both
groups, except in terms of discharge disposition, which suggests
that elderly recipients are appropriately selected.Whether current
selection protocols are too restrictive cannot be ascertained from
these data because the elderly patient group represented only 2.6%
of LTs in the study population.
This study has several potential limitations. It used a large retro-
spective database cohort derived from two administrative data-
bases. Although this linkage of the UHC and SRTR databases
represents >40% of all OLTs performed in adults in the USA over
the 5-year period, it is possible that the database is skewed toward
areas of higher competition and organ availability. It is also pos-
sible that the data would differ if all LTs were accounted for;
however, the demographic data used in the present study were
examined and compared with data in the entire SRTR file and
were found to be similar in donor, recipient and centre character-
istics. The present data do not include non-transplant-related
comorbidities or provide the ability to address longterm factors
related to survival, including understanding of adherence to
immunosuppression and compliance. This is an important con-
straint because elderly recipients were found to have a higher rate
of mortality within a 2-year follow-up, but this does not appear to
be associated with graft-related issues because graft survival was
similar across the groups. Linkage with the UHC database pro-
vides additional insight into the perioperative outcomes and
resource utilization of these patients; however, patient data are
available only for the study time period evaluated. This limitation
in the availability of data accounts for the relatively short median
follow-up time reported in this study.
In summary, elderly patients represent <3% of LT recipients
operated during 2007–2011. These patients have perioperative
outcomes and graft survival similar to those in younger adults.
After adjusting for patient differences with a case-controlled
analysis, patient survival was found to be similar among elderly
patients and those aged 18–69 years. Survival differences in the
present unadjusted analysis suggest the importance of patient
selection and the maintenance of postoperative health after LT.
Based on this analysis, elderly patients may represent an unders-
erved patient population that would benefit from LT. Future
studies should focus on evaluating risk factors for poor outcomes
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